News
- Author:
- Randy Dotinga
Publish date: June 9, 2023
Psychiatrists must grapple with questions of law, capacity, and resources.
News
- Author:
- Randy Dotinga
Publish date: June 6, 2023
Psychiatrists urge colleagues to ignore myths about venerable drugs and consider them in appropriate patients.
News
- Author:
- Randy Dotinga
Publish date: June 5, 2023
Benign ethnic neutropenia “does not increase the risk of clozapine-induced severe neutropenia,” said Dr. Laura Clarke.
News
- Author:
- Randy Dotinga
Publish date: June 5, 2023
Opioid users stick around when they get more withdrawal relief, addiction clinic finds.
News
- Author:
- Randy Dotinga
Publish date: June 4, 2023
Almost all patients who skipped chemotherapy avoided invasive disease/death at 3 years.
News
- Author:
- Randy Dotinga
Publish date: June 4, 2023
Controlling estrogen seems to give premenopausal women a lifespan boost, but strategy remains uncommon.
News
- Author:
- Randy Dotinga
Publish date: June 1, 2023
As overdose epidemic continues, new regulations change landscape for opioid addiction therapy.
News
- Author:
- Randy Dotinga
Publish date: May 31, 2023
Having battled Hodgkin lymphoma and the health care system itself, a young public relations specialist is on a mission.
News
- Author:
- Randy Dotinga
Publish date: May 31, 2023
Clinicians emphasized quick access to antipsychotic medication and more staff communication.
News
- Author:
- Randy Dotinga
Publish date: May 26, 2023
There are sparse data about the value of the procedure, which has fallen out of favor.
News
- Author:
- Randy Dotinga
Publish date: May 24, 2023
Black Americans are more likely to be diagnosed at older ages and to die from the disease.
News
- Author:
- Randy Dotinga
Publish date: May 23, 2023
Researchers blame racism for both findings of an analysis of three North Carolina hospitals.
News
- Author:
- Randy Dotinga
Publish date: May 22, 2023
Most patients in a small study reached undetectable measurable disease after taking combo therapy for high-risk CLL.
News
- Author:
- Randy Dotinga
Publish date: May 18, 2023
Oncologists are still trying to understand the best drug targets and the value of combo treatments.
News
- Author:
- Randy Dotinga
Publish date: May 17, 2023
In a small study, 56% of oncologists revised plans after getting results of HER2DX tests.
